| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |